Skip to main content
Clinical Trials/ACTRN12620000382976
ACTRN12620000382976
Completed
未知

A follow-up of the Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP) and their children: REVAMP Extend

niversity of Malawi, College of Medicine0 sites862 target enrollmentMarch 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
anaemia
Sponsor
niversity of Malawi, College of Medicine
Enrollment
862
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 20, 2020
End Date
August 12, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Malawi, College of Medicine

Eligibility Criteria

Inclusion Criteria

  • Participants must have participated in the main REVAMP trial, or be a child born to a participant of the parent study to be included in this substudy.
  • Participants meeting the following criteria were included in the parent trial (main REVAMP trial):
  • 1\.Confirmed singleton pregnancy at 13\-26 weeks gestation
  • 2\.Moderate to severe anaemia not requiring an immediate blood transfusion (Hb \<10g/dl)
  • 3\.Negative malaria parasitaemia
  • 4\.Resident in the study catchment area of Blantyre and Zomba district
  • 5\.Plan to deliver at a health facility
  • 6\.Written informed consent (including assent if \<18 years old)

Exclusion Criteria

  • Non participation in the main REVAMP trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials